Product Details
VABYSMO#
Faricimab6 mg
Injection
ROA
Intravenous; Intramuscular
Applicant Name
Roche Products Limited
NRN
A6-100124
Status
Active
Composition
ATC Code
S01LA09
Product Category
Vaccines and Biologics
Marketing Category
Prescription-only Medicine (POM)
Packsize
1* 0.24mL
Product Description
11 NF-BV-303096 VABYSMO Faricimab Faricimab 6.00 mg, L-Histidine 155 ug, Acetic Acid 30% QS to pH 5.5, L-Methionine 52.2 ug, Sodium Chloride 73.1 ug, D-Sucrose 2.74mg, Polysorbate 20 20.00 ug, Water for Injection QS to 0.05 mL. Vaccines & Biologicals Biologics Imported Products 1* 0.24mL * 1 filter needle 12/21/2022 ROCHE PRODUCTS LIMITED, 2nd Floor, 48/50 Isaac John Street Ikeja GRA, Lagos. 8056292219 angela.essien@roche.com F. Hoffmann-La Roche Ltd Switzerland, Wurmisweg, Kaiseraugst, CH-4303, F. Hoffmann-La Roche Ltd Switzerland, Wurmisweg, Kaiseraugst, CH-4303, Switzerland A6-100124 Faricimab Vaccines & Biologicals 1* 0.24mL * 1 filter needle N/A Vabysmo is presented in a Pack size of one glass vial and one sterile 5 µm blunt transfer filter needle (18-gauge x 1½ inch, 1.2 mm x 40 mm) for singl INJECTION ROCHE PRODUCTS LIMITED 8056292219 angela.essien@roche.com & 9TH FLOOR, MOBOLAJI BANK ANTHONY IKEJA LAGOS Imported F. Hoffmann-La Roche Ltd Switzerland, Wurmisweg, Kaiseraugst, CH-4303 *New Product Registration +41 61 688 71 73 thorsten.herkert@roche.com F. Hoffmann-La Roche Ltd Switzerland, Wurmisweg, Kaiseraugst, CH-4303
Manufacturer Name
F Hoffman La-Roche Ltd Wurmisweg 4303 Kaiseraugst
Manufacturer Country
SWITZERLAND
Approval Date
2023-07-03
Expiry Date
2028-07-02